Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies

被引:87
作者
Molloy, S. A. [1 ]
Rowan, E. N. [1 ]
O'Brien, J. T. [1 ]
McKeith, I. G. [1 ]
Wesnes, K. [1 ]
Burn, D. J. [1 ]
机构
[1] Newcastle Gen Hosp, Ageing & Hlth Wolfson Res Ctr, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
基金
英国医学研究理事会;
关键词
D O I
10.1136/jnnp.2006.098079
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Levodopa (L-dopa) is the gold standard treatment for Parkinson's disease, but a lack of clear efficacy combined with a perceived liability to neuropsychiatric side effects has limited L-dopa use in patients with parkinsonism and dementia. Therefore, the effect of L-dopa on the cognitive profile of dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD) is unclear. Aim: To ascertain the acute and long-term effects of L-dopa on aspects of attention and cognition in patients with DLB and PDD, and to compare these with the effects in Parkinson's disease. Method: Baseline cognitive and motor function was assessed off L-dopa in patients with Parkinson's disease (n = 22), PDD (n = 27) and DLB (n = 11) using standard "bedside'' measures and a computerised programme detecting reaction times and accuracy. All patients then underwent an acute L-dopa challenge with subsequent subjective and objective analysis of alertness, verbal recall, reaction times and accuracy. The same parameters were measured after 3 months on L-dopa to assess the prolonged effect. Results: Acute L-dopa challenge considerably improved motor function and subjective alertness in all patients without compromising either reaction times or accuracy, but increased fluctuations were noted in both groups with dementia. Neuropsychiatric scores improved in patients with Parkinson's disease both with and without dementia on L-dopa at 3 months. Although patients with Parkinson's disease also had better mean global cognitive function at this time, mean verbal attention and memory deteriorated, and patients with PDD had slower reaction times in some tests. No patient had a marked deterioration over this time. Patients with DLB did not experience any adverse cognitive or neuropsychiatric effects after 3 months of L-dopa treatment. Conclusion: The use of L-dopa in patients with parkinsonism with dementia does not adversely affect cognitive function.
引用
收藏
页码:1323 / 1328
页数:6
相关论文
共 40 条
[1]   Range of neuropsychiatric disturbances in patients with Parkinson's disease [J].
Aarsland, D ;
Larsen, JP ;
Lim, NG ;
Janvin, C ;
Karlsen, K ;
Tandberg, E ;
Cummings, JL .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (04) :492-496
[2]   Risk of dementia in Parkinson's disease - A community-based, prospective study [J].
Aarsland, D ;
Andersen, K ;
Larsen, JP ;
Lolk, A ;
Nielsen, H ;
Kragh-Sorensen, P .
NEUROLOGY, 2001, 56 (06) :730-736
[3]   A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia [J].
Aarsland, D ;
Ballard, C ;
Larsen, JP ;
McKeith, I .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2001, 16 (05) :528-536
[4]   Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease [J].
Albanese, A ;
Bonuccelli, U ;
Brefel, C ;
Chaudhuri, KR ;
Colosimo, C ;
Eichhorn, T ;
Melamed, E ;
Pollak, P ;
Van Laar, T ;
Zappia, M .
MOVEMENT DISORDERS, 2001, 16 (02) :197-201
[5]  
*APA, 2000, DIANG STAT MAN DIS
[6]   Parkinson disease neuropathology - Later-developing dementia and loss of the levodopa response [J].
Apaydin, H ;
Ahlskog, JE ;
Parisi, JE ;
Boeve, BF ;
Dickson, DW .
ARCHIVES OF NEUROLOGY, 2002, 59 (01) :102-112
[7]   Catecholamine modulation of prefrontal cortical cognitive function [J].
Arnsten, AFT .
TRENDS IN COGNITIVE SCIENCES, 1998, 2 (11) :436-447
[8]  
Bäckman L, 2000, AM J PSYCHIAT, V157, P635
[9]   Fluctuations in attention - PD dementia vs DLB with parkinsonism [J].
Ballard, CG ;
Aarsland, D ;
McKeith, I ;
O'Brien, J ;
Gray, A ;
Cormack, F ;
Burn, D ;
Cassidy, T ;
Starfeldt, R ;
Larsen, JP ;
Brown, R ;
Tovee, M .
NEUROLOGY, 2002, 59 (11) :1714-1720
[10]   USE OF ANALOG SCALES IN RATING SUBJECTIVE FEELINGS [J].
BOND, A ;
LADER, M .
BRITISH JOURNAL OF MEDICAL PSYCHOLOGY, 1974, 47 (SEP) :211-218